How would you optimally manage a patient with a MDS/MPN overlap syndrome who has both transfusion-dependent anemia and marked thrombocytosis?  

Would this change with someone who has a history of thrombosis (e.g. DVT/PE, MI, CVA)?

Would this change with someone who is more fit vs more frail?



Answer from: Medical Oncologist at Academic Institution